Key Finding
Probiotic, prebiotic, or synbiotic supplementation significantly reduced total testosterone (SMD: -1.47), insulin resistance, inflammatory markers, and improved lipid profiles in women with PCOS across 26 randomized controlled trials.
If you have polycystic ovary syndrome (PCOS), you know how challenging it can be to manage symptoms like weight gain, irregular hormones, and blood sugar imbalances. Exciting new research suggests that caring for your gut health may be a powerful piece of the puzzle.
A large scientific review published in the Journal of Ovarian Research analyzed 26 carefully controlled studies involving women with PCOS, most aged in their mid-to-late twenties. Researchers looked at whether taking probiotics (beneficial bacteria), prebiotics (the fiber that feeds those bacteria), or synbiotics (a combination of both) could improve key health markers. Participants took these supplements for anywhere from 8 to 24 weeks.
The results were encouraging across the board. Women who took these gut-supporting supplements showed meaningful reductions in body weight, BMI, and waist circumference. Their insulin levels and insulin resistance improved, which is significant because blood sugar dysregulation is a core challenge in PCOS. Inflammation markers dropped, cholesterol profiles improved with lower LDL and higher HDL, and perhaps most strikingly, total testosterone levels fell significantly — a hormone that drives many of PCOS's most distressing symptoms like excess hair growth and acne.
So what does this mean if you are exploring acupuncture for PCOS? Traditional Chinese Medicine has long viewed the gut and reproductive health as deeply connected. Acupuncture and TCM dietary guidance already aim to support digestion, reduce inflammation, and regulate hormonal balance. This research suggests that adding probiotic or prebiotic support to an integrative care plan could amplify those benefits, working alongside acupuncture to address PCOS from multiple angles.
If you are interested in a whole-body approach to managing PCOS, speak with a licensed acupuncturist or integrative practitioner who can tailor a plan to your individual needs.
This systematic review and meta-analysis (Journal of Ovarian Research, 2025) synthesized findings from 26 RCTs examining prebiotic, probiotic, and synbiotic supplementation in women with PCOS (mean age 25–29 years; follow-up 8–24 weeks). Databases searched included PubMed, Cochrane, Embase, Scopus, and Web of Science through October 2025. Biotics supplementation produced statistically significant reductions in weight (SMD: -0.57), BMI (SMD: -0.42), waist circumference (SMD: -0.78), fasting insulin (SMD: -0.60), HOMA-IR (SMD: -0.79), MDA (SMD: -0.77), TG (SMD: -0.62), LDL-C (SMD: -0.71), and total testosterone (SMD: -1.47). HDL-C (SMD: +0.38) and total antioxidant capacity (SMD: +0.58) improved significantly. The largest effect size was observed for testosterone reduction. Clinically, these findings support integrating gut microbiome modulation into PCOS management protocols. For TCM practitioners, this evidence complements acupuncture's established roles in insulin sensitization and HPO axis regulation, suggesting a rationale for adjunctive probiotic recommendations within an integrative PCOS treatment strategy.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 A systematic review of 214 studies found that acupuncture and moxibustion improve endometrial receptivity in IVF-ET patients by enhancing uterine lining thickness, blood flow, and hormone levels through multiple molecular mechanisms including VEGF-mediated angiogenesis and AMPK/mTOR autophagy pathways.
📌 Live birth rate — the outcome most important to patients undergoing acupuncture-assisted IVF — remains one of the least-supported measures in existing clinical trial evidence, highlighting a critical gap between research priorities and patient concerns.
📌 Acupoint application therapy significantly increased high-quality embryo rates to 47% in ovarian endometriosis IVF patients compared to 31% in the placebo group, while normalizing dysregulated follicular steroid hormone levels linked to impaired oocyte yield.